PHP
OPRX icon

Parkman Healthcare Partners’s OptimizeRx OPRX Stock Holding History

Parkman Healthcare Partners’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2M Sell
350,347
-379,022
-52% -$2.18M 0.21% 70
2026
Q1 		$4.58M Buy
729,369
+190,720
+35% +$1.77M 0.47% 62
2025
Q4 		$6.6M Buy
538,649
+29,038
+6% +$474K 0.63% 50
2025
Q3 		$10.4M Buy
509,611
+2,188
+0.4% +$34.7K 1.09% 33
2025
Q2 		$6.85M Buy
507,423
+32,423
+7% +$355K 0.79% 50
2025
Q1 		$4.11M Buy
+475,000
New +$2.9M 0.49% 59

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BAM
Bullseye Asset Management Denver, Colorado $197M AUM 20.63% 1-Year Est. Return

Parkman Healthcare Partners's OPRX Position: Q2 2026 in Review

Parkman Healthcare Partners reduced its OptimizeRx (OPRX) stake by 52% in Q2 2026, selling an estimated $2.18M and leaving 350,347 shares worth $2M. The position accounts for 0.21% of the portfolio, ranked #70.

Parkman Healthcare Partners first reported a position in OPRX in Q1 2025 and has held it in 6 quarters since. The position peaked at $10.4M in Q3 2025. 112 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • Parkman Healthcare Partners held 350,347 shares of OptimizeRx worth $2M as of Q2 2026.
  • Parkman Healthcare Partners sold 379,022 OptimizeRx shares in Q2 2026, an estimated $2.18M.
  • OptimizeRx made up 0.21% of Parkman Healthcare Partners's portfolio in Q2 2026, its #70 holding.
  • Parkman Healthcare Partners first reported a position in OptimizeRx in Q1 2025 and has held it in 6 quarters since.
  • Parkman Healthcare Partners's OptimizeRx position peaked at $10.4M in Q3 2025.
  • 112 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.